Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients

Örebro University, Sweden42 enrolled

Overview

The purpose of this study is to determine whether sustainable daily physical activity is effective in improving biological indicators of health and self-reported quality of life in men with prostate cancer.

Living with prostate cancer is a unique challenge faced by millions of men across the globe. Existing research has indicated many potential methods of attenuating prostate cancer progression and preserving patients' quality of life, but is lacking in definitive conclusions regarding the effectiveness of these methods in practice. This study seeks to further investigate the impact of post-diagnosis physical activity on biological indicators of health and self-reported quality of life in a cohort of men with prostate cancer in Sweden. Participants are randomized to either a walking intervention group, which encourages walking 10,000 steps per day for one year, or to a standard-or-care control group, and followed for 11 weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Prostatic Neoplasm

Interventions

Walking InterventionBEHAVIORAL

Participants are provided with the current standard of prostate cancer care, and are additionally encouraged to walk 10,000 steps per day, as measured by pedometers provided at start of intervention. Once a week, participants will take part in a group walk with 7-8 other participants and a research nurse. Participants are also encouraged to keep a walking journal, in which they record the number of steps they walk each day. This journal is submitted to investigators at the end of the intervention period.

Standard of CareOTHER

Participants are provided with the current standard of prostate cancer care, but are not assigned to a physical activity intervention.

Eligibility

Sex: MALEMin age: 40 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 80 years or younger * Histologic confirmation of prostate cancer * Clinically or pathologically staged as locally advanced or early metastatic prostate cancer * Diagnosis within 1 year of study enrollment * Willing and able to walk 10,000 steps per day Exclusion Criteria: * Age greater than 80 years old at enrollment * Inability to understand the language spoken in host country * Physically unable to walk 100 meters unassisted * Diagnosed with dementia or severe psychiatric disease * Any prior cancer diagnosis * Has experienced a myocardial infarction or stroke within six months of cancer diagnosis

Locations (1)

Orebro University

Örebro, Narke, Sweden